Order For This Paper, Written Essays or Similar Assignment Help Services.

Fill the details/instructions form and checkout for your essay - pro writers; top college graduates only in less than 5 mins, NO AI—Plagiarism-free!.

Posted: October 26th, 2023

A 54-year-old woman with chronic pain due to inflammatory arthritis

Read the following case studies and search for the guidelines that answers the specific questions?
CASE 1
A 54-year-old woman with chronic pain due to inflammatory arthritis presents to your clinic stating that she is having a “flare” of her arthritis but is out of her Oxycontin® and immediate-release oxycodone. She is aware that it is too early to fill her prescriptions, but she insists that she will be traveling out of state and “really needs” her medications.

Question: How do you Approach This Patient in the community setting?

What is the implications of prescribing this medication? Please provide evidence.

CASE 2
A 27-year-old woman on buprenorphine-naloxone (Suboxone®) for treatment of opioid dependence is admitted to the hospital with severe abdominal pain due to a perforated gastric ulcer. She received hydromorphone in the ED, and is urgently taken to the operating room. Postoperatively, she is on a patient-controlled analgesic (PCA) pump containing fentanyl. Her last dose of buprenorphine-naloxone was 20 h prior to the surgery; her daily dose is 16 mg.

Question: How can Pain be Managed in Patients who are Taking Buprenorphine-Naloxone? What Adjustments to her Medication Regimen can be Recommended?

CASE 3
A 20-year-old man is brought to the emergency department (ED) by his family for evaluation. His family reports that he failed out of school in his second year at a local community college. He admits to escalating struggles with prescription pain pills (prescription opioids), and then heroin use. He appears to be in opioid withdrawal; he describes anorexia and diarrhea, and is yawning and sweating on exam. He has a Clinical Opioid Withdrawal Scale (COWS) score of 15, indicating moderate withdrawal. His provider orders clonidine, ondansetron, and 2/0.5 mg sublingual buprenorphine/naloxone, with a plan to observe him in the ED. The provider subsequently receives a concerned call from the hospital pharmacist. Question: The Pharmacist States That the Provider is Unable to Administer Buprenorphine in the ED Without an X-Waivered DEA Number. Is This Accurate?

COWS.jpg

Federal precription guidelines.jpg

CASE 4
A 23-year-old woman attends an outpatient treatment program and office-based buprenorphine clinic. She has been doing well while maintained on 16 mg/day of buprenorphine. Recently though, she has missed group sessions and provided a urine for drug screening that tested positive for clonazepam and amphetamine. One of the other members in her group reported that they saw a “urine bottle fall out of her purse” as it spilled next to her chair in a group session; her counselor was unaware of this event.

QUESTION: WHAT ARE THE POLICIES REGARDING THE USE OF ILLICIT SUBSTANCES OR URINE ADULTERATION OR SUBSTITUTION DURING SUBSTANCE ABUSE TREATMENT?

CASE 1:
When approaching a patient requesting early refills of controlled substances, it is important to establish trust and communicate care through active listening (Upshur et al., 2019). One could say “I understand you’re in pain and want relief for your trip. However, unexpectedly refilling prescriptions could jeopardize your health. Let’s discuss non-opioid options and make a plan for your flare that prioritizes well-being over the long-term.” Prescribing early refills promotes misuse and non-medical use, putting the patient at risk for addiction, overdose and legal issues (Dowell et al., 2016). Non-opioid therapies and a treatment agreement focused on optimal functioning, not just pain scores, are preferable (Chou et al., 2019).
CASE 2:
For patients on buprenorphine therapy who require acute pain management, supplemental opioids may be considered but require close monitoring (Webster et al., 2020). Buprenorphine has a high affinity for mu-opioid receptors, potentially blocking the analgesic effects of full agonists like fentanyl (Kornfield and Manfredi, 2010). The patient’s buprenorphine dose could be held for 24-48 hours before and after surgery to allow full agonists to take effect, with the understanding that this may precipitate withdrawal (Webster et al., 2020). Non-opioid adjuncts like NSAIDs, acetaminophen, gabapentinoids and ketamine could provide adequate analgesia when added to reduced opioid doses (Chou et al., 2019).
CASE 3:
While providers with an X-waiver can prescribe buprenorphine for opioid use disorder in various settings, including emergency departments, the pharmacist is correct that the provider in this case would need an X-waiver number to do so (SAMHSA, 2022). However, buprenorphine can be given in the ED for acute pain or to treat life-threatening overdose under a provider’s DEA number, not requiring an X-waiver (SAMHSA, 2022). For this patient, supportive care and monitoring are most urgent. Transferring to an inpatient facility with buprenorphine-waivered providers for ongoing treatment would be prudent (Webster et al., 2020).
CASE 4:
Substance abuse treatment programs generally have policies prohibiting illicit substance use and restricting on-site access to diverted medications (SAMHSA, 2018). Positive drug tests or evidence of diversion like the reported urine bottle incident would warrant clinical review and could result in adjusted treatment, increased supervision or even discharge from the program (SAMHSA, 2018). The goal is to provide a safe environment focused on recovery, not continued use (SAMHSA, 2018). In this case, discussing the events openly and creating a plan with clear expectations would be appropriate to support the patient’s long-term recovery goals (SAMHSA, 2018).
In summary, an individualized, multi-modal approach considering each patient’s unique needs, the treatment setting and guidelines is most prudent for managing pain in complex cases involving substance use disorders or controlled prescription medications. Non-opioid options, close monitoring, open communication and prioritizing overall health and functioning over solitary symptom relief are key. Please let me know if any part of the discussion requires further elaboration.
Chou R, Deyo R, Devine B, et al. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Agency for Healthcare Research and Quality; 2014.
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464
Kornfield, R., & Manfredi, L. E. (2010). Effectiveness of full versus partial opioid agonist treatment for chronic non-cancer pain: a systematic review. The journal of pain : official journal of the American Pain Society, 11(10), 894–906. https://doi.org/10.1016/j.jpain.2010.03.001
SAMHSA. (2022). Medication-Assisted Treatment (MAT). https://www.samhsa.gov/medication-assisted-treatment
SAMHSA. (2018). Substance Abuse Confidentiality Regulations. https://www.samhsa.gov/about-us/who-we-are/laws-regulations/confidentiality-regulations-faqs
Upshur C, Luckmann R, Savageau J. Primary Care Provider Concerns About Management of Chronic Pain in Community Clinic Populations. J Gen Intern Med. 2019;34(4):649–655. doi:10.1007/s11606-018-4784-6
Webster LR, Cochella S, Dasgupta N, et al. An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United States. Pain Med. 2020;22(1):45–56. https://doi.org/10.1093/pm/pnz312

Order | Check Discount

Tags: , , ,

Find The Best Writers, Tutors & Assignment Experts!

2025 Special Offer! Get 20-25% Off On ALL Your Orders!

Why trust us?

Every student wants the best grades and that’s our Focus

Graduate Level Writers

Our team consists of outstanding writers who have specialized knowledge in specific subject areas and professionals experienced in academic research writing. They hold at least a graduate degree—230 with Masters and MSN qualifications, experts carefully selected and trained to ensure the best quality of our work. .

College Students Prices

We’re dedicated to bringing on board top-notch writers who can provide excellent work at prices that make sense for college students; affordable papers. Our goal? To give you the best bang for your buck without ever compromising on the quality of our essay writing services—or the content of your paper. #Don’t forget to use the DISCOUNT code in the COUPONS section of the order form before you pay!.

100% Human Written

The service guarantees that our final work is 100% original, rearched and human written expertly. We are committed to delivering plagiarism-free and AI-free work to each university/college student's 'write my paper' request. To uphold this promise, we check every draft for any possible instances of duplication, wrong citation, grammar errors and artificiality before we send it to you. Thus, you can always rely on us to write genuine and high-standard content for your essay assignments.

How it works

When you trust to place an order with Homework Ace Tutors, here is what happens:

Complete the Order Form

Please fill out our order form completely, providing as much detail as possible in all the required fields.

Assignment of Writer

We carefully review your order and assign it to a skilled writer with the specific expertise needed to handle it. The writer then creates your content entirely from scratch.

Order in Progress and Submission

You, along with the support team and your assigned writer, communicate directly throughout the process. Once the final draft is delivered, you can either approve it or request edits, paraphrasing, or a complete revision.

Giving us Feedback(review our essay service)

Ultimately, we value your feedback on how your experience went. You can also explore testimonials from other clients. Additionally, you have the option to recommend or select your preferred writer for any future orders.

Write My Essay For Me